Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial
Kim A. Reiss, Rosemarie Mick, Ursina Teitelbaum, Mark H. O’Hara, Charles Schneider, Ryan Massa, Thomas B. Karasic, Rashmi Tondon, Chioma Onyiah, Mary Kate Gosselin, Alyssa Donze, Susan M. Domchek, Robert H. Vonderheide
Topics & Concepts
IpilimumabMedicineNivolumabInternal medicinePancreatic cancerOncologyProgression-free survivalRegimenChemotherapyCancerMaintenance therapyPhases of clinical researchBlockadeSurgeryGastroenterologyImmunotherapyReceptorPancreatic and Hepatic Oncology ResearchPARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers